These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25941605)

  • 1. Using α radiation to boost cancer immunity?
    Gorin JB; Guilloux Y; Morgenstern A; Chérel M; Davodeau F; Gaschet J
    Oncoimmunology; 2014 Oct; 3(9):e954925. PubMed ID: 25941605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Damage-associated molecular patterns in tumor radiotherapy.
    Ashrafizadeh M; Farhood B; Eleojo Musa A; Taeb S; Najafi M
    Int Immunopharmacol; 2020 Sep; 86():106761. PubMed ID: 32629409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunotherapy as non-myeloablative conditioning for allogeneic marrow transplantation.
    Bethge WA; Wilbur DS; Sandmaier BM
    Leuk Lymphoma; 2006 Jul; 47(7):1205-14. PubMed ID: 16923548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of dendritic cells by DAMPs in ALA-PDT treated SCC tumor cells.
    Wang X; Ji J; Zhang H; Fan Z; Zhang L; Shi L; Zhou F; Chen WR; Wang H; Wang X
    Oncotarget; 2015 Dec; 6(42):44688-702. PubMed ID: 26625309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of 213Bi-alpha radioimmunotherapy for multiple myeloma.
    Couturier O; Faivre-Chauvet A; Filippovich IV; Thédrez P; Saï-Maurel C; Bardiès M; Mishra AK; Gauvrit M; Blain G; Apostolidis C; Molinet R; Abbe JC; Bataille R; Wijdenes J; Chatal JF; Chérel M
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3165s-3170s. PubMed ID: 10541359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of the human pathogenic fungi Cryptococcus neoformans and Histoplasma capsulatum to gamma-radiation versus radioimmunotherapy with alpha- and beta-emitting radioisotopes.
    Dadachova E; Howell RW; Bryan RA; Frenkel A; Nosanchuk JD; Casadevall A
    J Nucl Med; 2004 Feb; 45(2):313-20. PubMed ID: 14960655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy.
    Adkins I; Fucikova J; Garg AD; Agostinis P; Špíšek R
    Oncoimmunology; 2014 Dec; 3(12):e968434. PubMed ID: 25964865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alpha-Radioimmunotherapy: principle and relevance in anti-tumor immunity].
    Ménager J; Gorin JB; Fichou N; Gouard S; Morgenstern A; Bruchertseifer F; Davodeau F; Kraeber-Bodéré F; Chérel M; Gaschet J; Guilloux Y
    Med Sci (Paris); 2016 Apr; 32(4):362-9. PubMed ID: 27137693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of LNCaP spheroids after treatment with an alpha-particle emitter (213Bi)-labeled anti-prostate-specific membrane antigen antibody (J591).
    Ballangrud AM; Yang WH; Charlton DE; McDevitt MR; Hamacher KA; Panageas KS; Ma D; Bander NH; Scheinberg DA; Sgouros G
    Cancer Res; 2001 Mar; 61(5):2008-14. PubMed ID: 11280760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined treatment of human colorectal tumor cell lines with chemotherapeutic agents and ionizing irradiation can in vitro induce tumor cell death forms with immunogenic potential.
    Frey B; Stache C; Rubner Y; Werthmöller N; Schulz K; Sieber R; Semrau S; Rödel F; Fietkau R; Gaipl US
    J Immunotoxicol; 2012; 9(3):301-13. PubMed ID: 22800185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative single-particle digital autoradiography with α-particle emitters for targeted radionuclide therapy using the iQID camera.
    Miller BW; Frost SH; Frayo SL; Kenoyer AL; Santos E; Jones JC; Green DJ; Hamlin DK; Wilbur DS; Fisher DR; Orozco JJ; Press OW; Pagel JM; Sandmaier BM
    Med Phys; 2015 Jul; 42(7):4094-105. PubMed ID: 26133610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha Particles Induce Autophagy in Multiple Myeloma Cells.
    Gorin JB; Gouard S; Ménager J; Morgenstern A; Bruchertseifer F; Faivre-Chauvet A; Guilloux Y; Chérel M; Davodeau F; Gaschet J
    Front Med (Lausanne); 2015; 2():74. PubMed ID: 26539436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell death triggered by alpha-emitting 213Bi-immunoconjugates in HSC45-M2 gastric cancer cells is different from apoptotic cell death.
    Seidl C; Schröck H; Seidenschwang S; Beck R; Schmid E; Abend M; Becker KF; Apostolidis C; Nikula TK; Kremmer E; Schwaiger M; Senekowitsch-Schmidtke R
    Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):274-85. PubMed ID: 15791436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining α-Radioimmunotherapy and Adoptive T Cell Therapy to Potentiate Tumor Destruction.
    Ménager J; Gorin JB; Maurel C; Drujont L; Gouard S; Louvet C; Chérel M; Faivre-Chauvet A; Morgenstern A; Bruchertseifer F; Davodeau F; Gaschet J; Guilloux Y
    PLoS One; 2015; 10(6):e0130249. PubMed ID: 26098691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation.
    Garg AD; Nowis D; Golab J; Vandenabeele P; Krysko DV; Agostinis P
    Biochim Biophys Acta; 2010 Jan; 1805(1):53-71. PubMed ID: 19720113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of Cell Killing Response from Low Linear Energy Transfer (LET) Radiation Originating from (177)Lu Radioimmunotherapy Targeting Disseminated Intraperitoneal Tumor Xenografts.
    Yong KJ; Milenic DE; Baidoo KE; Brechbiel MW
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27196891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of multiple myeloma treatment by CD138 antigen targeting with bismuth-213 and Melphalan chemotherapy.
    Gouard S; Pallardy A; Gaschet J; Faivre-Chauvet A; Bruchertseifer F; Morgenstern A; Maurel C; Matous E; Kraeber-Bodéré F; Davodeau F; Chérel M
    Nucl Med Biol; 2014 May; 41 Suppl():e30-5. PubMed ID: 24759272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer.
    McDevitt MR; Barendswaard E; Ma D; Lai L; Curcio MJ; Sgouros G; Ballangrud AM; Yang WH; Finn RD; Pellegrini V; Geerlings MW; Lee M; Brechbiel MW; Bander NH; Cordon-Cardo C; Scheinberg DA
    Cancer Res; 2000 Nov; 60(21):6095-100. PubMed ID: 11085533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High hydrostatic pressure induces immunogenic cell death in human tumor cells.
    Fucikova J; Moserova I; Truxova I; Hermanova I; Vancurova I; Partlova S; Fialova A; Sojka L; Cartron PF; Houska M; Rob L; Bartunkova J; Spisek R
    Int J Cancer; 2014 Sep; 135(5):1165-77. PubMed ID: 24500981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.